Ena Respiratory

About:

Ena Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections.

Website: https://enarespiratory.com/

Twitter/X: innavac

Top Investors: AustralianSuper, U.S. Department of Defense, Hostplus, Brandon Capital, Minderoo Foundation

Description:

Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines. Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterial dissemination to the lungs.